Results 1 to 10 of about 1,905 (147)

Socio-demographic determinants of low sexual desire and hypoactive sexual desire disorder: a population-based study in Iran [PDF]

open access: greenBMC Women's Health, 2020
Background Various socio-demographic factors have been introduced as the determinants of Low Sexual Desire (LSD), but whether these variables can also contribute to the Hypoactive Sexual Desire Disorder (HSDD), remains uncertain. In this study, we sought
Zeinab Hamzehgardeshi   +5 more
doaj   +8 more sources

Characteristics of Chinese women in need of enhanced sexual health attention and at risk of hypoactive sexual desire disorder [PDF]

open access: goldBMC Women's Health, 2023
Background The target population for women’s sexual health services in China was unclear. To identify high-risk individuals with psychological barriers to sexual health-seeking behaviors and those at high risk of hypoactive sexual desire disorder (HSDD),
Lan Luo, Jingjing Huang, Huafang Li
doaj   +4 more sources

Evaluation and Management of Hypoactive Sexual Desire Disorder [PDF]

open access: goldSexual Medicine, 2018
Introduction: Hypoactive sexual desire disorder (HSDD) often has a negative impact on the health and quality of life of women; however, many women do not mention—let alone discuss—this issue with their physicians.
Anita H. Clayton, MD   +2 more
doaj   +3 more sources

Prevalence of Hypoactive Sexual Desire Disorder Among Sexually Active Postmenopausal Women With Metabolic Syndrome at a Public Hospital Clinic in Brazil: A Cross-sectional Study [PDF]

open access: goldSexual Medicine, 2020
Aims: To evaluate the prevalence of hypoactive sexual desire disorder (HSDD) among postmenopausal women diagnosed with metabolic syndrome (MS) and to compare it to that of a control group without MS.
Gustavo Maximiliano Dutra da Silva, MD, PhD   +4 more
doaj   +3 more sources

Flibanserin: A controversial drug for female hypoactive sexual desire disorder

open access: goldIndustrial Psychiatry Journal, 2018
Sexual functioning is an integral part of human life. Female sexual dysfunction (FSD) adversely affects quality of life and general well-being. The Food and Drug Administration recently approved flibanserin, for treatment of female hypoactive sexual ...
Rashmi Baid, Rakesh Agarwal
doaj   +3 more sources

Hypoactive sexual desire disorder caused by antiepileptic drugs

open access: diamondJournal of Human Reproductive Sciences, 2015
Female sexual dysfunction is common but poorly understood sexual problem in women. Sexual dysfunction in female is multi-factorial in origin and also observed with intake of drug acting on central nervous system.
M Singh   +3 more
doaj   +3 more sources

Systematic Review of l-Arginine for the Treatment of Hypoactive Sexual Desire Disorder and Related Conditions in Women [PDF]

open access: yesPharmacy, 2021
This systematic review evaluates the efficacy and safety of l-arginine alone or in combination for the treatment of women with hypoactive sexual desire disorder (HSDD) or related conditions, such as female sexual interest/arousal disorder and female ...
Nicole E. Cieri-Hutcherson   +6 more
doaj   +2 more sources

Drug flibanserin–in hypoactive sexual desire disorder

open access: diamondGynecology and Obstetrics Clinical Medicine, 2022
Hypoactive sexual desire disorder (HSDD) is a widely known type of female sexual dysfunction that could also cause emotional distress and relationship problems.
Pugazhenthan Thangaraju   +2 more
doaj   +2 more sources

Psychometric Properties of the Sexual Interest and Desire Inventory-Female for Diagnosis of Hypoactive Sexual Desire Disorder: The Persian Version [PDF]

open access: greenIranian Journal of Psychiatry, 2016
Objective: Hypoactive sexual desire Disorder (HSDD) is a common sexual problem among women. Sexual interest and desire inventory –female (SIDI-F) has been widely validated and used to measure sexual desire in women. The aim of this study was to determine
Mina Malary   +4 more
doaj   +3 more sources

Effects of Flibanserin on Subdomain Scores of the Female Sexual Function Index in Women With Hypoactive Sexual Desire Disorder [PDF]

open access: yesSexual Medicine, 2022
: Introduction: Flibanserin treatment increases sexual desire and satisfying sexual events while decreasing distress in certain women diagnosed with acquired, generalized hypoactive sexual desire disorder (HSDD).
James A. Simon, MD   +6 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy